المؤلفون: Luciana Yamamoto de Almeida, Diego A. Pereira-Martins, Isabel Weinhäuser, César Ortiz, Larissa A. Cândido, Ana Paula Lange, Nayara F. De Abreu, Sílvia E. S. Mendonza, Virgínia M. de Deus Wagatsuma, Mariane C. Do Nascimento, Helder H. Paiva, Raquel M. Alves-Paiva, Camila C. O. M. Bonaldo, Daniele C. Nascimento, José C. Alves-Filho, Priscila S. Scheucher, Ana Sílvia G. Lima, Jan Jacob Schuringa, Emanuele Ammantuna, Tiziana Ottone, Nelida I. Noguera, Cleide L. Araujo, Eduardo M. Rego

المصدر: Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: epidermal growth factor receptor (EGFR), erlotinib, gefitinib, all-trans retinoic acid (ATRA), acute promyelocytic leukemia (APL), ATRA-resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.686445/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/7571ff921fee43699747c4b3cd44329e

المؤلفون: Luciana Yamamoto de Almeida (11493331), Diego A. Pereira-Martins (11493334), Isabel Weinhäuser (11493337), César Ortiz (11493340), Larissa A. Cândido (11493343), Ana Paula Lange (9318199), Nayara F. De Abreu (11493346), Sílvia E. S. Mendonza (11493349), Virgínia M. de Deus Wagatsuma (11493352), Mariane C. Do Nascimento (11493355), Helder H. Paiva (11493358), Raquel M. Alves-Paiva (11493361), Camila C. O. M. Bonaldo (11493364), Daniele C. Nascimento (11493367), José C. Alves-Filho (5224700), Priscila S. Scheucher (11493370), Ana Sílvia G. Lima (11493373), Jan Jacob Schuringa (8173461), Emanuele Ammantuna (11493376), Tiziana Ottone (10101109), Nelida I. Noguera (11493379), Cleide L. Araujo (11493382), Eduardo M. Rego (7252424)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, epidermal growth factor receptor (EGFR), erlotinib, gefitinib, all-trans retinoic acid (ATRA), acute promyelocytic leukemia (APL), ATRA-resistance, ATO-resistance, arsenic trioxide (ATO)

Relation: https://figshare.com/articles/figure/Image_2_The_Combination_of_Gefitinib_With_ATRA_and_ATO_Induces_Myeloid_Differentiation_in_Acute_Promyelocytic_Leukemia_Resistant_Cells_jpeg/16690975

الاتاحة: https://doi.org/10.3389/fonc.2021.686445.s002

المؤلفون: Luciana Yamamoto de Almeida (11493331), Diego A. Pereira-Martins (11493334), Isabel Weinhäuser (11493337), César Ortiz (11493340), Larissa A. Cândido (11493343), Ana Paula Lange (9318199), Nayara F. De Abreu (11493346), Sílvia E. S. Mendonza (11493349), Virgínia M. de Deus Wagatsuma (11493352), Mariane C. Do Nascimento (11493355), Helder H. Paiva (11493358), Raquel M. Alves-Paiva (11493361), Camila C. O. M. Bonaldo (11493364), Daniele C. Nascimento (11493367), José C. Alves-Filho (5224700), Priscila S. Scheucher (11493370), Ana Sílvia G. Lima (11493373), Jan Jacob Schuringa (8173461), Emanuele Ammantuna (11493376), Tiziana Ottone (10101109), Nelida I. Noguera (11493379), Cleide L. Araujo (11493382), Eduardo M. Rego (7252424)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, epidermal growth factor receptor (EGFR), erlotinib, gefitinib, all-trans retinoic acid (ATRA), acute promyelocytic leukemia (APL), ATRA-resistance, ATO-resistance, arsenic trioxide (ATO)

Relation: https://figshare.com/articles/dataset/Table_1_The_Combination_of_Gefitinib_With_ATRA_and_ATO_Induces_Myeloid_Differentiation_in_Acute_Promyelocytic_Leukemia_Resistant_Cells_docx/16690996

الاتاحة: https://doi.org/10.3389/fonc.2021.686445.s009